| 2026 |
Amsalu, A., Haidari, H., Mirco, B., Rudolph-Stringer, V., Walter, S., Antipov, A., . . . Kopecki, Z. (2026). Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients.. Orphanet J Rare Dis, 21(1), 11 pages.
DOI |
| 2026 |
Van Vo., Haidari, H., Amsalu, A., Antipov, A., Cowin, A. J., Wagstaff, M. J., . . . Kopecki, Z. (2026). Next-generation antimicrobial dermal matrix eradicates polymicrobial biofilms and modulates inflammation in in vitro and ex vivo wound models.. Scientific reports.
DOI |
| 2025 |
Honda Okubo, Y., Sajkov, D., Wauchope, B., Turner, J. V., Vote, B., Antipov, A., . . . Petrovsky, N. (2025). Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults. Vaccine, 49(126744), 1-11.
DOI Scopus1 WoS1 |
| 2025 |
Antipov, A., & Petrovsky, N. (2025). One health adjuvant selection for vaccines against zoonotic infections. Exploration of Medicine, online, 1-18.
DOI |
| 2025 |
Amsalu, A., Alvaro, A., Huang, S., May, A., Antipov, A., Quinn, L., . . . Kopecki, Z. (2025). Risk factors for antimicrobial resistance in paediatric burn infections: Insights from a retrospective cohort study. Burns, 51(6, article no. 107584), 1-9.
DOI |
| 2025 |
Antipov, A., & Petrovsky, N. (2025). One Health adjuvant selection for vaccines against zoonotic infections. Exploration of Medicine, 6.
DOI Scopus2 |
| 2024 |
McLelland, D. J., Lynch, M., Vogelnest, L., Eden, P., Wallace, A., Weller, J., . . . Petrovsky, N. (2024). Safety and immunogenicity of an adjuvanted recombinant spike protein-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, SpikeVet™, in selected carnivora, primates and artiodactyla in Australian zoos. Journal of Veterinary Pharmacology and Therapeutics, 47(4), 308-321.
DOI Scopus6 WoS4 Europe PMC5 |
| 2024 |
Sanchez, P. L., Andre, G., Antipov, A., Petrovsky, N., & Ross, T. M. (2024). Advax-SM™-adjuvanted COBRA (H1/H3) hemagglutinin influenza vaccines. Vaccines, 12(5, article no. 455), 1-20.
DOI Scopus2 WoS2 Europe PMC3 |
| 2023 |
Honda Okubo, Y., Antipov, A., Andre, G., Barati, S., Kafi, H., & Petrovsky, N. (2023). Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants. Immunology, 170(2), 193-201.
DOI Scopus12 WoS12 Europe PMC11 |
| 2020 |
Antipov, A., Brizuela, M., Blessing, W. W., & Ootsuka, Y. (2020). Alpha2-adrenergic receptor agonists prevent emotional hyperthermia. Brain Research, 1732(146678), 1-6.
DOI Scopus5 WoS4 Europe PMC3 |
| 2019 |
Brizuela, M., Antipov, A., Blessing, W. W., & Ootsuka, Y. (2019). Activating dopamine D2 receptors reduces brown adipose tissue thermogenesis induced by psychological stress and by activation of the lateral habenula. Scientific Reports, 9(1, article no. 19512), 1-10.
DOI Scopus17 WoS16 Europe PMC9 |
Available For Media Comment.